medica glp-1 coverage CMS Issues Guidance on Anti-Obesity Drugs Medicare is piloting coverage for

In case of dropout, an intention-to-treat approach was applied in order to prevent risk of bias as long as the assessed variable itself was available

What to Do If GLP-1 Isnt Working Track your habits: Keep a food and activity log to see where adjustments can be made

November 4, 2025: With over 2,900 lawsuits pending in the federal GLP-1 litigation, attorneys say we will likely cross the 3,000 case watermark by the end of the year

While the inherent mechanism of action of GLP-1R agonists mediates their glucose dependence, studies in rats suggest that SUs may uncouple this dependence

Metabolic indicators that may be associated with reduced GLP-1 activity include: Persistent elevated blood glucose levels , particularly postprandial (after-meal) hyperglycaemia Difficulty achieving or maintaining a healthy weight despite dietary efforts Increased appetite and reduced satiety after meals, leading to frequent snacking Diagnosis of type 2 diabetes or non-diabetic hyperglycaemia (NDH, sometimes called prediabetes), conditions where GLP-1 response is often blunted Features of metabolic syndrome , including central obesity, hypertension, and dyslipidaemia Individuals may also notice practical symptoms such as feeling hungry shortly after eating substantial meals, experiencing energy crashes following carbohydrate-rich foods, or finding portion control particularly challenging